Defining, Estimating, and Communicating Overdiagnosis in Cancer Screening

Affiliations

¹ Geisel School of Medicine at Dartmouth and Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, New Hampshire (L.D.).
² University of Arizona College of Medicine-Phoenix, Phoenix, Arizona (D.B.P.).
³ Abt Associates, Cambridge, Massachusetts (M.W.).
⁴ Kaiser Permanente Research Affiliates Evidence-based Practice Center and Kaiser Permanente Center for Health Research, Portland, Oregon (J.S.L.).

Comment

Louise Davies et al. Ann Intern Med. 2018.

. 2018 Dec 4;169(11):824.

doi: 10.7326/L18-0517.

¹ Geisel School of Medicine at Dartmouth and Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, New Hampshire (L.D.).
² University of Arizona College of Medicine-Phoenix, Phoenix, Arizona (D.B.P.).
³ Abt Associates, Cambridge, Massachusetts (M.W.).
⁴ Kaiser Permanente Research Affiliates Evidence-based Practice Center and Kaiser Permanente Center for Health Research, Portland, Oregon (J.S.L.).

No abstract available

Comment on

Defining, Estimating, and Communicating Overdiagnosis in Cancer Screening.
Davies L, Petitti DB, Martin L, Woo M, Lin JS. Davies L, et al. Ann Intern Med. 2018 Jul 3;169(1):36-43. doi: 10.7326/M18-0694. Epub 2018 Jun 26. Ann Intern Med. 2018. PMID: 29946705
Defining, Estimating, and Communicating Overdiagnosis in Cancer Screening.
Carter SM, Barratt A, Doust J, Degeling C. Carter SM, et al. Ann Intern Med. 2018 Dec 4;169(11):823-824. doi: 10.7326/L18-0515. Ann Intern Med. 2018. PMID: 30508436 No abstract available.